The Long Run with Luke Timmerman
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
May 1, 2024
Vineeta Agarwala, a general partner at A16Z's Bio & Health fund, discusses AI's impact on drug discovery. Topics include AI automating tasks, learning from negative data, and the hype around AI in healthcare. She emphasizes the importance of small startups in curating data for AI, the necessity of patience in biotech investments, and the future of collaborative learning in drug discovery.
56:33
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- AI accelerates drug discovery in biotech
- Invest in talent and upskilling for research
Deep dives
AI Applications in Biotech and Healthcare
Artificial intelligence is being utilized across the biotech and healthcare sectors to expedite drug discovery, enhance healthcare delivery, and predict patient outcomes. The podcast episode delves into various applications of AI in automating tasks, augmenting expert decision-making, and generating amazing insights for better patient care.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
